Skip to main content
. 2018 Aug 31;13(8):e0200433. doi: 10.1371/journal.pone.0200433

Fig 5. Induction of apoptosis in MDA-MB-231 breast cancer cells following EgKI-1 treatment.

Fig 5

(a) Control, untreated cells were alive, being Annexin V-/PI-; (b) 20% of cells treated with the lower EgKI-1 concentration (0.25 μM) were in early apoptosis (Annexin V+/PI-); (c) Cells treated with the higher EgKI-1 (1 μM) concentration exhibited the highest percentage of late apoptotic/ early necrotic cells (Annexin V+/PI+).